The Effects of Externally Paced Exercise on Cognitive Performance and Stress in College Aged Students

May 25, 2021 updated by: New York Institute of Technology
The purpose of the study is to investigate the acute effect of martial art exercise and aerobic exercise on cognitive performance in college age students. Cognitive performance is a term that encompasses our cognitive processes such as working memory, and executive functioning (decision making); research has found that externally paced (EP) exercise improves cognitive performance and executive functioning (EF). EP activities require decision making skills and higher-level executive functioning. Previous research studies have shown that acute as well as long term aerobic exercise improves cognitive performance Internally paced (IP) exercise requires less attention on task, which may result in less significant improvements in cognitive performance and executive function. However, there is limited research examining the effect that martial art exercise has on these higher-level cognitive functions.Theoretically, the martial art class will improve provide greater stimulation to the higher levels of the brain, causing a greater improvement in the executive function scores when compared to walking. This leads to the question, are externally paced aerobic activities more effective than an acute bout of aerobic exercise in improving executive function in college-aged adults? The investigators hypothesized that martial art training will have a greater impact on executive functioning than aerobic exercise in college-aged adults.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

The purpose of the study is to investigate the acute effect of a beginner martial art class and aerobic exercise on cognitive performance in college age students. Cognitive performance is a term that encompasses our cognitive processes such as working memory, and executive functioning (response inhibition); research has found that externally paced (EP) exercise improves cognitive performance and executive functioning (EF). EP activities require decision making skills and higher-level executive functioning. Internally paced (IP) exercise requires less attention on task, which may result in less significant improvements in cognitive performance and executive function. Previous research studies have shown that acute as well as long term aerobic exercise improves cognitive performance. However, there is limited research examining the effect that a martial art class, an external paced exercise, has on these higher-level cognitive functions in college -aged subjects. A study performed by Douris et. al provides a more accurate measure of EP exercise and cognition. Martial arts were used as the complex EP activity. EF in the martial arts group showed greater improvement than the aerobic exercise condition. This was attributed to the complexities of the movement patterns and the associated cortical demands. This study aligns with our current belief that EP activities will have a greater effect than IP activities. The research on the comparison of martial art exercise (externally paced exercise) versus aerobic exercise (internally paced exercise) on executive function is limited to the previous study by the principal investigator utilizing experienced middle-aged martial artists and we presently intend to investigate college aged adults as compared to the previously investigated middle -aged..The current study looks to determine how complex exercise would impact executive functioning. Martial art training requires reactionary movements, quick thinking and decision making, all of which are components of EF. Walking is a relatively simple task that does not require much conscious or cortical control. The investigators plan to have the participants participate in a beginning martial art class and a one hour walk.. Theoretically, the martial art class will improve provide greater stimulation to the higher levels of the brain, causing a greater improvement in the executive function scores when compared to walking. This leads to the question, are externally paced aerobic activities more effective than an acute bout of aerobic exercise in improving executive function in college-aged adults? The proposed research design will be utilizing a randomized cross over repeated measures design. The independent variables are the two one-hour conditions and the dependent variables are the change in Stroop test scores, and stress Visual Analog Scale (VAS) results. In order to test the hypothesis, the investigators will perform a dependent t-test for each dependent variable. An alpha level of p<0.05 will be used for all statistical comparisons. The hypothesis is that an externally paced activity such as martial art exercise will have a greater effect on enhancing executive functioning and will improve stress levels in college aged young adults when compared to an internally paced activity such as walking.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
16

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • New York
      • Old Westbury, New York, United States, 11568
        • New York Institute of Technology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years to 30 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age range: 18-30 years
  • Good overall health
  • Exercise at least two days/week

Exclusion Criteria:

  • Any cardiopulmonary conditions including asthma within the last 6 months.
  • Any major musculoskeletal injuries (i.e. torn ligaments, bone fractures, etc.) over the last 6 months.
  • Any other health issues that would interfere with a subject's safety during exercise.
  • Any auditory/vestibular impairments.
  • Uncorrected visual problems and color blindness.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
EXPERIMENTAL: One group taking part in 2 separate conditions
The proposed research design will be utilizing a randomized cross over repeated measures design. Subjects will take part in two separate conditions: 1) One hour of a beginning martial art class (EP), and 2) One hour walk at 4.0 mph pace (IP).
Other: Exercise
One hour of a beginning martial art class ,and a one hour walk at 4.0 mph pace.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Executive function
Time Frame: 10 minutes
For the Stroop tests: the subject will be asked to read words of colors, state the colors of various letters to test processing speed. Subjects will also state the color of the font of a word when the actual word describes a conflicting color. This tests response inhibition, which is a subdivision of executive function. Tower of London which entails a subject is shown the correct organization and is given a specific number of moves to accomplish the task which tests for the problem solving domain of executive function
10 minutes

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Stress
Time Frame: 2 minutes
Visual Analog Scale 0-10
2 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
New York Institute of Technology

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Peter Douris, New York Institute of Technology

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
March 1, 2021

Primary Completion (ACTUAL)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
May 1, 2021

Study Completion (ACTUAL)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
May 1, 2021

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
December 16, 2020

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
December 16, 2020

First Posted (ACTUAL)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
December 21, 2020

Study Record Updates

Last Update Posted (ACTUAL)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
May 27, 2021

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 25, 2021

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
March 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • BHS-1535

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All IPD that underlie results in a publication

IPD Sharing Time Frame

6 months after publication

IPD Sharing Access Criteria

All requests will be reviewed by the principal investigator

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings